CNS Neuroscience and Therapeutics
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Pharmacology
Q1
└
Pharmacology (medical)
Q1
└
Physiology (medical)
Q1
Publisher
SJR 2025
1.741
Q1
SJR Score
H-Index
105
Citations / Doc (2yr)
6.46
Total Docs. (latest)
510
Total Citations (3yr)
8,240
Publication type
Journals
ISSN
17555949, 17555930
Coverage
2008-2026
Journal Rank
#1,861
Subject Categories
Pharmacology
Q1
Pharmacology (medical)
Q1
Physiology (medical)
Q1
Psychiatry and Mental Health
Q1
Subject Areas
Aims & Scope
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation.
The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 510 |
| Total Docs. (3 years) | 1,254 |
| Total Refs. | 30,545 |
| Total Citations (3 years) | 8,240 |
| Citable Docs. (3 years) | 1,199 |
| Citations / Doc. (2 years) | 6.46 |
| Ref. / Doc. | 59.89 |
| % Female | 43.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.